Home / Products / Peptides / Details
video
Cardiogen Peptide Powder

Cardiogen Peptide Powder

Appearance: White to off white powder
Specification: 98% min
CAS: 857267-11-9
Molecular Formula: C18H31N7O9
Molecular Weight: 489.48
EINECS: 206-976-6
Shelf Life: 2 Years Proper Storage
Stock: Fresh Stock
Certificate: COA,GMP,ISO,HACCP
Service: OEM&ODM Service

Product Introduction

High-Purity Cardiogen Peptide Powder for Bulk Procurement in China – Cardiac Protection, Anti-Fibrosis & Ischemic Repair Peptide Raw Material for Research and Formulation Development

Key Points:

Cardiac protection | Cardiomyocyte homeostasis regulation | Ischemic injury mitigation | Anti-fibrotic effect | Myocardial tissue repair promotion | p53 pathway anti-apoptotic regulation | Suitable for research & formulation development

 

Product Overview

 

Cardiogen Peptide Powder is a synthetic tetrapeptide bioregulator. Its core sequence is Alanine-Glutamic acid-Aspartic acid-Arginine (Ala-Glu-Asp-Arg, single-letter: AEDR). This short-chain peptide focuses on myocardial tissue protection and functional regulation.

 

Its main advantage is its tissue-specific targeting capability, preferentially acting on cardiomyocytes and cardiac fibroblasts. By regulating cardiomyocyte activity, inhibiting fibrosis, and mitigating ischemic injury through multiple pathways, it overcomes limitations of traditional cardiac protection raw materials, which often have single-target action and limited specificity.

 

Produced using standardized solid-phase peptide synthesis under GMP conditions, its linear tetrapeptide structure ensures high purity, low impurities, and stable bioactivity. Extensive preclinical studies demonstrate its effectiveness in myocardial protection, ischemic injury repair, and fibrosis inhibition, suitable for overseas research, formulation development, and functional product R&D. It also shows potential applications in oncology research, making it a premium raw material in cardiovascular health-related studies.

 

COA

 

Item Specification Result
Appearance White to off white powder Conform
Purity (HPLC) ≥98.0% 99.11%
MS Consistent Consistent
Conclusion The product complies with the requirements.

 

Mechanism of Action

 

Cardiogen Peptide Powder exerts cardiac protection via tetrapeptide structure and myocardial targeting:

● Recognized by cardiomyocytes and fibroblasts, penetrates membranes, partially enters nuclei, regulates proliferation, apoptosis, and fibroblast activity.

● Modulates p53 pathway, reduces unnecessary apoptosis, enhances antioxidant defense, mitigates ischemia and fibrosis, and maintains tissue homeostasis.

● Selectively induces hemorrhagic necrosis in abnormal vasculature while protecting healthy cardiac cells.

 

Product  Applications

 

1. Pharmaceutical Research Applications
Used in myocardial protection, cardiac repair, fibrosis, and heart failure-related formulation research.

2. Cardiovascular Research Material
Suitable for studies involving myocardial injury, fibrosis, angiogenesis, and cardiomyocyte regulation.

3. Functional Formulation Development
Applicable to cardiovascular health, anti-aging, and functional product research applications.

4. Custom Peptide Development
Supports peptide optimization, derivatization, and targeted cardioprotective research projects.

 

Benefits of Products

 

● Targeted Cardiac Research Potential
Supports cardiomyocyte and cardiac fibroblast regulation in cardiovascular research applications.

● Multi-Pathway Cardioprotective Activity
Applicable to studies involving myocardial protection, fibrosis regulation, oxidative stress, and ischemic injury repair.

● Supported by Preclinical Research
Preclinical studies indicate potential benefits in myocardial injury, fibrosis, heart failure, and related research models.

● Flexible Purity & Packaging Options
Available in multiple purity grades and packaging sizes for laboratory research, pilot studies, and bulk production.

 

Detailed Functions

 

● Neurocortical Regulation
Supports neurotransmitter balance, neuronal activity, and cortical function research.

● Cognitive & Memory Support
Applicable to learning, memory, and age-related cognitive research models.

● Neuroprotective Research Potential
Supports studies involving neuronal protection, anti-apoptotic pathways, and neural repair mechanisms.

● Neuroinflammation Modulation
Helps regulate inflammatory responses and supports a healthy neural microenvironment.

● Synaptic Plasticity Support
Supports synaptic signaling, connectivity, and neurotransmission research.

● Ischemic Brain Injury Research
Applicable to studies involving neuronal recovery and ischemia-related neural function support.

 

Core advantages

 

● Comprehensive Quality Traceability
Each batch is supported with complete COA documentation.

● Global Export Compliance
Animal-free production with MSDS, COA, and export documentation supporting international procurement requirements.

● Stable Supply Capacity
Scalable production, flexible packaging, and temperature-controlled shipping for reliable global delivery.

● Professional Technical Support
Technical assistance available for formulation development, application guidance, and research support.

 

Quality Assurance 

 

1. Raw Material Control: High-purity amino acids and strict reagent selection ensure tetrapeptide accuracy.

2. Production Control: GMP cleanroom, sterile operations, temperature & humidity monitoring, safe from contaminants.

3. Testing Control: HPLC & MS validate purity, sequence, and impurities. Moisture, TFA, microbiology, endotoxin monitored.

4. Compliance Control: Meets global standards and peptide import regulations, full export documentation.

5. After-Sales Control: Batch traceability, fast issue resolution, technical support.

 

FAQ

 

Q1: What is the difference between Cardiogen Peptide Powder and traditional cardiac protection materials?
A: Traditional cardiac protection materials typically target a single pathway, which limits their specificity and effectiveness. Cardiogen Peptide Powder is multi-pathway and tissue-specific, providing safer and more precise cardiac protection. 

 

Q2: What is the recommended research dosage?
A: Subcutaneous injection: 100–1000 mcg (typical: 500 mcg). In vitro studies: 10–100 nM. Dose-dependent effects have been observed in tumor studies. Professional guidance is available for experimental design.

 

factory

cardiogen-peptide-powder-gmp-manufacturing-facility.jpg

high-purity-cardiogen-peptide-production-factory.jpg

cardiogen-peptide-raw-material-manufacturer-china.jpg

 

Certificates

cardiogen-peptide-powder-coa-certificate-analysis.jpg

cardiogen-peptide-msds-quality-documentation.jpg

Shipping & Packing

 

bulk-cardiogen-peptide-powder-packaging-supplier.jpg

 

Ordering Information

 

We provide high-purity, stable, and GMP-compliant Cardiogen Peptide Powder, suitable for research, formulation, and functional product development. 

 

Contact:
Whatsapp & Mobile: +86 19991242181

Email: sales@hdmbio.com

Hot Tags: cardiogen peptide powder, China cardiogen peptide powder manufacturers, suppliers, factory, Cartalax Peptide Powder, Cetrorelix Acetate Powder, Elcatonin Powder, Epithalon Peptide Powder, Pinealon Peptide Powder, Semax Acetate Powder

Send Inquiry

Home

Phone

E-mail

Inquiry

Bag